Cullen Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $75.6M | Buy |
2,693,507
+596,176
| +28% | +$15.9M | 0.78% | 43 |
|
|
2025
Q4 | $52.2M | Sell |
2,097,331
-161,356
| -7% | -$4.07M | 0.57% | 51 |
|
|
2025
Q3 | $57.6M | Sell |
2,258,687
-1,384,891
| -38% | -$34.2M | 0.63% | 49 |
|
|
2025
Q2 | $88.3M | Sell |
3,643,578
-1,079,744
| -23% | -$25.2M | 1.01% | 35 |
|
|
2025
Q1 | $120M | Sell |
4,723,322
-51,058
| -1% | -$1.34M | 1.38% | 35 |
|
|
2024
Q4 | $127M | Buy |
4,774,380
+545,406
| +13% | +$14.8M | 1.48% | 32 |
|
|
2024
Q3 | $122M | Buy |
4,228,974
+372,130
| +10% | +$10.9M | 1.33% | 37 |
|
|
2024
Q2 | $108M | Sell |
3,856,844
-641,387
| -14% | -$17.7M | 1.24% | 38 |
|
|
2024
Q1 | $125M | Buy |
4,498,231
+1,919,887
| +74% | +$53.3M | 1.39% | 36 |
|
|
2023
Q4 | $74.2M | Sell |
2,578,344
-1,402,358
| -35% | -$42.4M | 1.1% | 35 |
|
|
2023
Q3 | $132M | Sell |
3,980,702
-88,866
| -2% | -$3.14M | 1.54% | 32 |
|
|
2023
Q2 | $149M | Buy |
4,069,568
+2,988
| +0.1% | +$116K | 1.33% | 32 |
|
|
2023
Q1 | $166M | Buy |
4,066,580
+1,019,440
| +33% | +$44M | 1.52% | 26 |
|
|
2022
Q4 | $156M | Sell |
3,047,140
-937,743
| -24% | -$45M | 2% | 18 |
|
|
2022
Q3 | $174M | Buy |
3,984,883
+310,028
| +8% | +$15.1M | 1.87% | 22 |
|
|
2022
Q2 | $193M | Sell |
3,674,855
-35,514
| -1% | -$1.81M | 1.94% | 15 |
|
|
2022
Q1 | $192M | Buy |
3,710,369
+48,971
| +1% | +$2.54M | 1.77% | 24 |
|
|
2021
Q4 | $216M | Sell |
3,661,398
-1,117,992
| -23% | -$55.4M | 2.03% | 17 |
|
|
2021
Q3 | $206M | Sell |
4,779,390
-171,544
| -3% | -$7.6M | 2.02% | 16 |
|
|
2021
Q2 | $194M | Buy |
4,950,934
+356,787
| +8% | +$13.9M | 1.87% | 19 |
|
|
2021
Q1 | $166M | Buy |
4,594,147
+3,446,388
| +300% | +$122M | 1.8% | 20 |
|
|
2020
Q4 | $42.2M | Sell |
1,147,759
-82,359
| -7% | -$3.02M | 2.35% | 15 |
|
|
2020
Q3 | $42.8M | Sell |
1,230,118
-290,117
| -19% | -$10.2M | 2.48% | 13 |
|
|
2020
Q2 | $47.2M | Sell |
1,520,235
-296,142
| -16% | -$10.1M | 2.65% | 13 |
|
|
2020
Q1 | $56.2M | Sell |
1,816,377
-74,766
| -4% | -$2.55M | 3.24% | 6 |
|
|
2019
Q4 | $70.3M | Buy |
1,891,143
+124,999
| +7% | +$4.45M | 2.76% | 9 |
|
|
2019
Q3 | $60.2M | Buy |
1,766,144
+44,316
| +3% | +$1.61M | 2.42% | 16 |
|
|
2019
Q2 | $70.8M | Buy |
1,721,828
+4,506
| +0.3% | +$179K | 2.76% | 10 |
|
|
2019
Q1 | $69.2M | Buy |
1,717,322
+6,197
| +0.4% | +$248K | 2.73% | 9 |
|
|
2018
Q4 | $70.9M | Sell |
1,711,125
-135,999
| -7% | -$5.65M | 3.06% | 7 |
|
|
2018
Q3 | $77.2M | Buy |
1,847,124
+7,077
| +0.4% | +$272K | 2.85% | 2 |
|
|
2018
Q2 | $63.3M | Sell |
1,840,047
-163,549
| -8% | -$5.59M | 2.4% | 16 |
|
|
2018
Q1 | $67.5M | Buy |
2,003,596
+39,304
| +2% | +$1.35M | 2.39% | 17 |
|
|
2017
Q4 | $67.5M | Sell |
1,964,292
-21,154
| -1% | -$721K | 2.32% | 20 |
|
|
2017
Q3 | $67.2M | Buy |
1,985,446
+87,947
| +5% | +$2.83M | 2.34% | 21 |
|
|
2017
Q2 | $60.5M | Sell |
1,897,499
-137,332
| -7% | -$4.33M | 2.13% | 26 |
|
|
2017
Q1 | $66M | Sell |
2,034,831
-506,721
| -20% | -$16M | 2.32% | 21 |
|
|
2016
Q4 | $78.3M | Buy |
2,541,552
+4,637
| +0.2% | +$142K | 2.7% | 15 |
|
|
2016
Q3 | $81.5M | Buy |
2,536,915
+92,183
| +4% | +$3.08M | 2.76% | 15 |
|
|
2016
Q2 | $81.7M | Sell |
2,444,732
-13,913
| -0.6% | -$444K | 2.88% | 14 |
|
|
2016
Q1 | $69.1M | Sell |
2,458,645
-38,618
| -2% | -$1.1M | 2.45% | 20 |
|
|
2015
Q4 | $76.5M | Sell |
2,497,263
-136,367
| -5% | -$4.29M | 2.58% | 18 |
|
|
2015
Q3 | $78.5M | Sell |
2,633,630
-124,688
| -5% | -$4M | 2.75% | 15 |
|
|
2015
Q2 | $87.7M | Buy |
2,758,318
+18,550
| +0.7% | +$605K | 2.8% | 15 |
|
|
2015
Q1 | $90.4M | Buy |
2,739,768
+92,036
| +3% | +$2.93M | 2.54% | 19 |
|
|
2014
Q4 | $78.3M | Buy |
2,647,732
+196,096
| +8% | +$5.62M | 2.13% | 27 |
|
|
2014
Q3 | $68.8M | Buy |
2,451,636
+15,283
| +0.6% | +$429K | 1.89% | 26 |
|
|
2014
Q2 | $68.6M | Buy |
+2,436,353
| New | +$69.4M | 1.78% | 27 |
|
Other funds holding PFE
VCM
VPM
Cullen Capital Management's PFE Position: Q1 2026 in Review
Cullen Capital Management increased its Pfizer (PFE) stake by 28% in Q1 2026, buying an estimated $15.9M and bringing the position to 2,693,507 shares worth $75.6M. The position accounts for 0.78% of the portfolio, ranked #43.
Cullen Capital Management first reported a position in PFE in Q2 2014 and has held it in 48 quarters since. The position peaked at $216M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Cullen Capital Management held 2,693,507 shares of Pfizer worth $75.6M as of Q1 2026.
- Cullen Capital Management bought 596,176 Pfizer shares in Q1 2026, an estimated $15.9M.
- Pfizer made up 0.78% of Cullen Capital Management's portfolio in Q1 2026, its #43 holding.
- Cullen Capital Management first reported a position in Pfizer in Q2 2014 and has held it in 48 quarters since.
- Cullen Capital Management's Pfizer position peaked at $216M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Cullen Capital Management's 13F filing for Q1 2026, filed 15 May 2026.